Skip to content

Gaseous oxygen enrichment before implantation as a means of improving organ function in liver transplantation

Randomized controlled clinical trial to investigate oxygen persufflation as adjunct in liver preservation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN00167887
Enrollment
116
Registered
2011-07-12
Start date
2011-08-01
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preservation and implantation of liver grafts Surgery Liver disease

Interventions

In the treatment group donor livers will be subjected to 2 hours of venous systemic oxygen persufflation prior to implantation, while still being stored in ice cold preservation solution.

Sponsors

University Hospital Duisburg-Essen (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients: 1. Men and women beyond 18 years of age 2. Resident in Germany 3. Scheduled for first liver transplantation and graft already available 4. Patient is willing and able to attend regular follow up examinations 5. Written informed consent Donor organs: 1. Donor grafts that are offered to the local transplant clinic for implantation, i.e. ?organ rescue offers? 2. Donor age above 65

Exclusion criteria

Exclusion criteria: 1. Listed as high urgency (HU) 2. Participation in this study at an earlier time 3. Simultaneous participation in other clinical trial 4. Present alcohol or drug abuse 5. Positive test for human immunodeficiency virus (HIV) 6. Pregnant or nursing

Design outcomes

Primary

MeasureTime frame
Serum peak value of systemic aspartate aminotransferase during the first three days after transplantation

Secondary

MeasureTime frame
1. Death 2. Retransplantation within 3 months after implantation 3. Time of stay in intensive-care-unit 4. Hepatic tissue perfusion one hour after revascularization 5. Early onset of graft dysfunction (based on Quick´s value as well as the use of a refined scoring-system for initial graft function based on a multi-parameter [aspartate transaminase (AST), alanine aminotransferase (ALT), Quick and bilirubin] score according to Heise and co-workers

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 28, 2026